Isthmus Partners’s Twist Bioscience TWST Stock Holding History

Isthmus Partners’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,145	Closed	-$435K	–	232
2026 Q1	$435K	Sell	9,145 -2,000	-18%	-$89.7K	0.05%	147
2025 Q4	$354K	Hold	11,145	–	–	0.04%	161
2025 Q3	$314K	Hold	11,145	–	–	0.07%	104
2025 Q2	$410K	Hold	11,145	–	–	0.05%	153
2025 Q1	$438K	Hold	11,145	–	–	0.05%	150
2024 Q4	$518K	Hold	11,145	–	–	0.06%	143
2024 Q3	$504K	Hold	11,145	–	–	0.06%	136
2024 Q2	$549K	Sell	11,145 -2,215	-17%	-$90.3K	0.06%	130
2024 Q1	$458K	Hold	13,360	–	–	0.05%	146
2023 Q4	$492K	Hold	13,360	–	–	0.06%	139
2023 Q3	$271K	Hold	13,360	–	–	0.04%	155
2023 Q2	$273K	Hold	13,360	–	–	0.04%	154
2023 Q1	$201K	Buy	+13,360	New	+$295K	0.03%	162

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Isthmus Partners's TWST Position: Q2 2026 in Review

Isthmus Partners sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 9,145 shares — an estimated $435K sold.

Isthmus Partners first reported a position in TWST in Q1 2023 and held it in 13 quarters. The position peaked at $549K in Q2 2024. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Isthmus Partners reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
Isthmus Partners sold 9,145 Twist Bioscience shares in Q2 2026, an estimated $435K.
Isthmus Partners first reported a position in Twist Bioscience in Q1 2023 and held it in 13 quarters.
Isthmus Partners's Twist Bioscience position peaked at $549K in Q2 2024.
335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Isthmus Partners's 13F filing for Q2 2026, filed 20 Jul 2026.